Try
ARTIVION, INC.
AORTUnited States
72 filed reports · 541 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
72 reports · Mar 2017 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 154 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 34 | 156 | Mar 2017 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 29 | 5,521 | Mar 2017 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 9 | 5,376 | Dec 2017 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 7, 2026 | 360 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 4 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 8, 2026 | 217 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 7, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 18, 2026 | 1,074 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 12, 2026 | 4 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 7, 2025 | 226 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 4 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 8, 2025 | 144 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 4 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 151 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 5, 2025 | 2 | Open |
Financial data
541 concepts · 11,053 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial523 concepts · 9,548 facts · Dec 2013 to Jul 2026
- Gross profit (US GAAP)57 · Mar 2015 to Jun 2026
- Net income loss57 · Mar 2015 to Jun 2026
- Revenue57 · Mar 2015 to Jun 2026
- Cash and cash equivalents at carrying value56 · Dec 2014 to Jun 2026
- Amortization of intangible assets53 · Dec 2015 to Jun 2026
- Comprehensive income net of tax53 · Dec 2015 to Jun 2026
- Cost of goods and services sold (US GAAP)53 · Dec 2015 to Jun 2026
- Depreciation depletion and amortization53 · Dec 2015 to Jun 2026
- Income tax expense benefit53 · Dec 2015 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities53 · Dec 2015 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets53 · Dec 2015 to Jun 2026
- Increase decrease in receivables53 · Dec 2015 to Jun 2026
- Inventories and deferred preservation costs53 · Dec 2015 to Jun 2026
- Investment income interest53 · Dec 2015 to Jun 2026
- Net income loss available to common stockholders basic53 · Dec 2015 to Jun 2026
- Net income loss available to common stockholders diluted53 · Dec 2015 to Jun 2026
- Operating expenses (US GAAP)53 · Dec 2015 to Jun 2026
- Operating income loss53 · Dec 2015 to Jun 2026
- Other nonoperating income expense53 · Dec 2015 to Jun 2026
- Payments to acquire property plant and equipment53 · Dec 2015 to Jun 2026
- Proceeds from issuance of common stock53 · Dec 2015 to Jun 2026
- Proceeds from payments for other financing activities53 · Dec 2015 to Jun 2026
- Realized investment gains losses53 · Dec 2015 to Jun 2026
- Research and development expense53 · Dec 2015 to Jun 2026
Product5 concepts · 862 facts · Dec 2015 to Jun 2026
- Revenue725 · Dec 2015 to Jun 2026
- Cost of goods and services sold (US GAAP)106 · Dec 2016 to Jun 2026
- Property, Plant & Equipment, Net17 · Mar 2017 to Jun 2021
- Intangible Assets (excluding Goodwill)13 · Mar 2017 to Jun 2021
- Asset impairment charges1 · Dec 2023
Segment5 concepts · 454 facts · Dec 2015 to Jun 2026
- Revenue195 · Dec 2015 to Jun 2026
- Cost of goods and services sold (US GAAP)116 · Dec 2015 to Jun 2026
- Gross profit (US GAAP)116 · Dec 2015 to Jun 2026
- Gross Profit18 · Dec 2023 to Jun 2026
- Goodwill9 · Dec 2016 to Dec 2025
Guidance5 concepts · 156 facts · Apr 2017 to Aug 2026
- Revenue Guidance74 · Apr 2017 to Aug 2026
- Revenue Growth Guidance40 · Feb 2020 to Aug 2026
- EPS (Diluted) Guidance24 · Apr 2017 to Feb 2020
- Gross Margin Guidance14 · Apr 2017 to Nov 2018
- Effective Tax Rate Guidance4 · Jul 2017 to Aug 2018
Geography3 concepts · 33 facts · Dec 2015 to Dec 2025
- Revenue26 · Dec 2015 to Dec 2025
- Germany4 · Dec 2019 to Dec 2022
- Germany {Member]3 · Dec 2018 to Dec 2020
Segments
1,349 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis28 members · 677 facts
- Preservation Services102 · Dec 2016 to Jun 2026
- Products102 · Dec 2016 to Jun 2026
- On X51 · Dec 2016 to Jun 2026
- Domestic Hospitals37 · Dec 2016 to Sep 2023
- International Distributor37 · Dec 2016 to Sep 2023
- International Hospitals37 · Dec 2016 to Sep 2023
- Other Products35 · Dec 2019 to Jun 2026
- Surgical Sealants35 · Dec 2019 to Jun 2026
- Cardiogenesis33 · Dec 2016 to Mar 2023
- Aortic Stent Grafts27 · Mar 2021 to Jun 2026
- Cardiac Tissue19 · Dec 2016 to Dec 2020
- Cardiogenesis Cardiac Laser Therapy19 · Dec 2016 to Dec 2020
- Per Clot19 · Dec 2016 to Dec 2020
- Photofix19 · Dec 2016 to Dec 2020
- Vascular Tissue18 · Dec 2016 to Dec 2020
- Aortic Stents And Stent Grafts14 · Dec 2018 to Dec 2022
- Jotec Ag14 · Dec 2017 to Sep 2020
- Bioglue12 · Dec 2017 to Dec 2020
- Bio Glue And Bio Foam12 · Dec 2016 to Sep 2019
- Total Preservation Services10 · Sep 2017 to Sep 2020
- Total Products10 · Sep 2017 to Sep 2020
- Medical Devices4 · Dec 2016 to Dec 2019
- Other Revenue4 · Jun 2022 to Sep 2023
- Neopatch3 · Sep 2020 to Dec 2020
- Cardio Genesis Cardiac Laser Therapy1 · Dec 2023
- He RO Graft1 · Dec 2016
- Nexus1 · Mar 2020
- Procol1 · Dec 2016
Statement business segments8 members · 454 facts
- Medical Devices174 · Dec 2015 to Jun 2026
- Preservation Services174 · Dec 2015 to Jun 2026
- Asia Pacific19 · Dec 2021 to Jun 2026
- Europe The Middle East And Africa Segments19 · Dec 2021 to Jun 2026
- Latin America19 · Dec 2021 to Jun 2026
- North America19 · Dec 2021 to Jun 2026
- Medical devices18 · Dec 2016 to Jun 2026
- Preservation services12 · Mar 2016 to Jun 2026
Product or serviceus-gaap:ProductOrServiceAxis20 members · 185 facts
- Per clot30 · Mar 2017 to Jun 2021
- Bio Glue And Bio Foam13 · Dec 2015 to Jun 2018
- Cardiac Tissue13 · Dec 2015 to Jun 2018
- Cardiogenesis Cardiac Laser Therapy13 · Dec 2015 to Jun 2018
- Per Clot13 · Dec 2015 to Jun 2018
- Photofix13 · Dec 2015 to Jun 2018
- Vascular Tissue13 · Dec 2015 to Jun 2018
- On X12 · Mar 2016 to Jun 2018
- Preservation Services9 · Dec 2015 to Jun 2018
- Total Preservation Services8 · Mar 2016 to Jun 2018
- Total Products8 · Mar 2016 to Jun 2018
- He RO Graft6 · Dec 2015 to Dec 2016
- Procol6 · Dec 2015 to Dec 2016
- Products6 · Mar 2017 to Jun 2018
- Cardiogenesis4 · Mar 2017 to Jun 2018
- Domestic Hospitals4 · Mar 2017 to Jun 2018
- International Distributor4 · Mar 2017 to Jun 2018
- International Hospitals4 · Mar 2017 to Jun 2018
- Jotec Ag3 · Dec 2017 to Jun 2018
- Medical Devices3 · Dec 2015 to Dec 2017
Statement geographicalsrt:StatementGeographicalAxis3 members · 27 facts
- Non Us10 · Dec 2016 to Dec 2025
- US10 · Dec 2016 to Dec 2025
- DE7 · Dec 2018 to Dec 2022
Statement geographicalus-gaap:StatementGeographicalAxis2 members · 6 facts
- Non Us3 · Dec 2015 to Dec 2017
- US3 · Dec 2015 to Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.